Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose ChemotherapyYuval Shaked, Robert S. Kerbel, Santosh Hariharan et al.|Cancer Research|2016Cited by 58
Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic diseaseFlorence T.H. Wu, Robert S. Kerbel|British Journal of Cancer|2018Cited by 46